Cyclosporine a therapy for multisystem Langerhans cell histiocytosis

Medical and Pediatric Oncology

Volumn 33, Issue 5, 1999, Pages 482-485

  Minkov, M ^a   Grois, N ^a   Broadbent, V ^b   Ceci, A ^c   Jakobson, A ^d   Ladisch, S ^e   Gadner, H ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BARI   (Italy)

^d UPPSALA UNIVERSITY   (Sweden)

^e CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Chemotherapy; Cyclosporine A; Langerhans cell histiocytosis

Indexed keywords

CYCLOSPORIN A; ETOPOSIDE; PREDNISOLONE; THYMOCYTE ANTIBODY; VINBLASTINE;

ARTICLE; DRUG EFFICACY; HISTIOCYTOSIS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT INDICATION;

ADOLESCENT; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DISEASE PROGRESSION; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0032707089     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199911)33:5<482::AID-MPO8>3.0.CO;2-Y     Document Type: Article

References (17)

1. Matus-Ridley M, Raney RB, Thawerani J, et al. Histiocytosis x in children: patterns of disease and results of treatment. Med Pediatr Oncol 1983;11:99-105.
2. Broadbent V, Pritchard J. Histocytosis X - current controversies. Arch Dis Child 1985;60:605-607.
3. Minkov M, Maschan A, Grois N, et al. Multisystem Langerhans cell histiocytosis (LCH): response to initial therapy heralds good prognosis. Med Pediatr Oncol 1996;27:579.
4. Grois N, Minkov M, Heitger A, et al. Response to therapy in multisystem Langerhans cell histiocytosis (LCH). Results from the DAL HX-83 and DAL HX-90 studies,. Med Pediatr Oncol 1996;27:573.
5. Mahmoud HH, Wang WC, Murphy SB. Cyclosporine therapy for advanced Langerhans cell histiocytosis. Blood 1991;77:721-725.
6. Mahmoud H, Broadbent V. Results of the Histiocyte Society Cyclosporine Salvage Therapy Questionnaire. Med Pediatr Oncol 1995;25:135.
7. Aricò M, Colella R, Conter V, et al. Cyclosporine therapy for refractory Langerhans cell histiocytosis, Med Pediatr Oncol 1995; 25:12-16.
8. Ladisch S, Gadner H, Aricò M, et al. LCH-I: a randomized trial of etoposide versus vinblastine in disseminated Langerhans cell histiocytosis. Med Pediatr Oncol 1994;23:107-110.
9. Writing Group of the Histiocyte Society. Histiocytosis syndromes in children. Lancet 1987;1:208-209.
10. Lahey E. Histiocytosis X: an analysis of prognostic factors. J Pediatr 1975;87:184-189.
11. Lahey ME. Histiocytosis X - comparison of three treatment regimens. J Pediatr 1975;87:179-183.
12. Lavin PT, Osband ME. Evaluating the role of therapy in histiocytosis-X. Hematol Oncol Clin North Am 1987;1:35-47.
13. Smith PJ, Ekert H, Campbell PE. Improved prognosis in disseminated histiocytosis. Med Pediatr Oncol 1976;2:371-377.
14. Gadner H, Heitger A, Grois N, et al., for the DAL HX-83 Study Group. Treatment strategy for disseminated Langerhans cell histiocytosis. Med Pediatr Oncol 1994;23:72-80.
15. Ladisch S, Gadner H. Treatment of Langerhans cell histiocytosis - evolution and current approaches. Br J Cancer 1994; 70(Suppl XXIII):S41-S46.
16. Colella R, de Terlizzi M, Loiacono G, et al. Cyclosporine therapy in recurrent Langerhans' cell histiocytosis. Preliminary results from the AIEOP ICL-R93 Study. Med Pediatr Oncol 1994;25: 145-145.
17. Komp DM, Herson J, Starling KA, et al. A staging system for histiocytosis X: a Southwest Oncology Group Study. Cancer 1981;47:798-800.